Valuation Methodologies in Life Sciences

Add to iCal Calendar 0

Date(s) - 9 Mar 2021
11:00 AM - 12:00 PM


Valuation Methodologies in Life Sciences
On March 9th, join BIO partner, Brex, for a fireside chat about Valuation Methodologies in Life Sciences.
Brex will be hosting John Selig, Managing Partner at WaveEdge Capital, and deep-diving into why the valuation of early-stage life sciences companies is so complex.

Mar 9, 2021

12:00 PM AZ

11:00 AM in Pacific Time (US and Canada)


Why is valuation of early stage life sciences companies so complex?

This webinar presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.

If you are an entrepreneur who is, or will be, raising financing, licensing an asset or selling your company, a private investor who wants to estimate and negotiate start-up share value, or any other professional who is active in the investing sector, you’ll benefit from this overview of the key concepts used in life sciences valuation discussions. This discussion will cover the various valuation methodologies used to assign a value to life science businesses and assets, the methodologies used in particular by pharma partners and venture capitalists, and an explanation of three fundamental concepts in life sciences valuation: risk-adjustment, cost of capital and net present value.